C164H166F6N32O6 — CID 160738663
(2S)-2-(3-cyanophenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-cyanophenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-N-[4-methyl-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[4-methyl-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[3-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[3-(trifluoromethyl)phenyl]acetamide (PubChem CID 160738663) has the molecular formula C164H166F6N32O6 and a molecular weight of 2795.34 g/mol. Its IUPAC name is (2S)-2-(3-cyanophenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-cyanophenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-N-[4-methyl-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[4-methyl-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[3-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[3-(trifluoromethyl)phenyl]acetamide.
| Compound Name | (2S)-2-(3-cyanophenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-cyanophenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-N-[4-methyl-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[4-methyl-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[3-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[3-(trifluoromethyl)phenyl]acetamide |
|---|---|
| PubChem CID | 160738663 |
| Molecular Formula | C164H166F6N32O6 |
| Molecular Weight | 2795.34 g/mol |
| Exact Mass | 2793.36 |
| IUPAC Name | (2S)-2-(3-cyanophenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-2-(3-cyanophenyl)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]acetamide;(2R)-N-[4-methyl-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2S)-N-[4-methyl-5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[[(2S)-2-(4-methylphenyl)propyl]amino]-2-phenylacetamide;(2R)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[3-(trifluoromethyl)phenyl]acetamide;(2S)-2-[2-(4-methylphenyl)ethylamino]-N-[5-(1-methylpyrazol-4-yl)-2-pyridinyl]-2-[3-(trifluoromethyl)phenyl]acetamide |
| SMILES | Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2cccc(C#N)c2)cc1.Cc1ccc(CCN[C@@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2cccc(C(F)(F)F)c2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2cccc(C#N)c2)cc1.Cc1ccc(CCN[C@H](C(=O)Nc2ccc(-c3cnn(C)c3)cn2)c2cccc(C(F)(F)F)c2)cc1.Cc1ccc([C@H](C)CN[C@@H](C(=O)Nc2cc(C)c(-c3cnn(C)c3)cn2)c2ccccc2)cc1.Cc1ccc([C@H](C)CN[C@H](C(=O)Nc2cc(C)c(-c3cnn(C)c3)cn2)c2ccccc2)cc1 |
| InChI | InChI=1S/2C28H31N5O.2C27H26F3N5O.2C27H26N6O/c2*1-19-10-12-22(13-11-19)21(3)15-30-27(23-8-6-5-7-9-23)28(34)32-26-14-20(2)25(17-29-26)24-16-31-33(4)18-24;2*1-18-6-8-19(9-7-18)12-13-31-25(20-4-3-5-23(14-20)27(28,29)30)26(36)34-24-11-10-21(15-32-24)22-16-33-35(2)17-22;2*1-19-6-8-20(9-7-19)12-13-29-26(22-5-3-4-21(14-22)15-28)27(34)32-25-11-10-23(16-30-25)24-17-31-33(2)18-24/h2*5-14,16-18,21,27,30H,15H2,1-4H3,(H,29,32,34);2*3-11,14-17,25,31H,12-13H2,1-2H3,(H,32,34,36);2*3-11,14,16-18,26,29H,12-13H2,1-2H3,(H,30,32,34)/t21-,27+;21-,27-;2*25-;2*26-/m111010/s1 |
| InChIKey | RVGYFYOYMNKGNH-KJDSPXEZSA-N |
| XLogP | 29.34 |
| TPSA | 478.62 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 48 |
| Heavy Atoms | 208 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2795.34 |
| LogP ≤ 5 | 29.34 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 32 |